Chronic intermittent hypoxia/reoxygenation facilitate amyloid-β generation in mice

Journal of Alzheimer's Disease

Volumn 37, Issue 2, 2013, Pages 325-333

  Shiota, Satomi ^a   Takekawa, Hidenori ^a   Matsumoto, Shin Ei ^a   Takeda, Kazuya ^a,b   Nurwidya, Fariz ^a   Yoshioka, Yasuko ^a   Takahashi, Fumiyuki ^a   Hattori, Nobutaka ^a   Tabira, Takeshi ^a   Mochizuki, Hideki ^c   Takahashi, Kazuhisa ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; amyloid peptide; hypoxia; obstructive sleep apnea

Indexed keywords

AMYLOID BETA PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; CHRONIC INTERMITTENT HYPOXIA; COGNITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROBLASTOMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REOXYGENATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANOXIA; ASPARTIC ACID ENDOPEPTIDASES; CELL LINE, TUMOR; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYPERBARIC OXYGENATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROBLASTOMA;

EID: 84883798746     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130419     Document Type: Article

References (47)

1. Cohen-Zion M, StepnowskyC, Marler, Shochat T, KripkeDF, Ancoli-Israel S (2001) Changes in cognitive function associated with sleep disordered breathing in older people. J Am Geriatr Soc 49, 1622-1627.
2. Mathieu A, Mazza S, Decary A, Massicotte-Marquez J, Petit D, Gosselin N, Malo J, Montplaisir J (2008) Effects of obstructive sleep apnea on cognitive function: A comparison between younger and older OSAS patients. Sleep Med 9, 112-120.
3. Ancoli-Israel S, Klauber MR, Butters N, Parker L, Kripke DF (1991) Dementia in institutionalized elderly: Relation to sleep apnea. J Am Geriatr Soc 39, 258-263.
4. YaffeK, LaffanAM,Harrison SL, Redline S, SpiraAP, Ensrud KE, Ancoli-Israel S, Stone KL (2011) Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 306, 613-619.
5. Douglas RM, Miyasaka N, Takahashi K, Latuszek-Barrantes A, Haddad GG, Hetherington HP (2007) Chronic intermittent but not constant hypoxia decreases NAA/Cr ratios in neonatal mouse hippocampus and thalamus. Am J Physiol Regul Integr Comp Physiol 292, R1254-R1259.
6. Reynolds CF 3rd, Kupfer DJ, Taska LS, Hoch CC, Sewitch DE, Restifo K, Spiker DG, Zimmer B, Marin RS, Nelson J, et al. (1985) Sleep apnea in Alzheimer's dementia: Correlation with mental deterioration. J Clin Psychiatry 46, 257-261.
7. Gehrman PR, Martin JL, Shochat T, Nolan S, Corey-Bloom J, Ancoli-Israel S (2003) Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. Am J Geriatr Psychiatry 11, 426-433.
8. Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS (2008) Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: A randomized controlled study. J Am Geriatr Soc 56, 2076-2081.
9. Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S (2009) Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: A preliminary study. J Clin Sleep Med 5, 305-309.
10. Matthews EE, AloiaMS(2011) Cognitive recovery following positive airway pressure (PAP) in sleep apnea. Prog Brain Res 190, 71-88.
11. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
12. Sisodia SS, Price DL (1995) Role of the beta-amyloid protein in Alzheimer's disease. FASEB J 9, 366-370.
13. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
14. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
15. Mochizuki A, Tamaoka A, Shimohata A, Komatsuzaki Y, Shoji S (2000) Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355, 42-43.
16. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161, 1869-1879.
17. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
18. Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N, Motomura K, Soejima N,Yamasaki R, HashimotoT,Tabira T, LaFerla FM, Kira J (2011) Apomorphine treatment in Alzheimer mice promoting amyloid-beta degradation. Ann Neurol 69, 248-256.
19. Wang J, Hara H, Makifuchi T, Tabira T (2008) Development and characterization of a TAPIR-like mouse monoclonal antibody to amyloid-beta. J Alzheimers Dis 14, 161-173.
20. Takeda K, Araki W, Tabira T (2004) Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci 19, 258-264.
21. Takeda K, Araki W, Akiyama H, Tabira T (2004) Aminotruncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. FASEB J 18, 1755-1757.
22. Takahashi F, Takahashi K, Okazaki T, Maeda K, Ienaga H, Maeda M, Kon S, Uede T, Fukuchi Y (2001) Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 24, 264-271.
23. Collins TJ (2007) ImageJ for microscopy. Biotechniques 43, 25-30.
24. Gouras GK, Almeida CG, TakahashiRH(2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26, 1235-1244.
25. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA (2001) Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 doubletransgenic mice. Neurosci Lett 306, 116-120.
26. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J Neurosci 26, 10129- 10140.
27. Tseng BP, Kitazawa M, LaFerla FM (2004) Amyloid betapeptide: The inside story. Curr Alzheimer Res 1, 231-239.
28. Kaushal N, RameshV, GozalD(2012) Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol 303, R19-R29.
29. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005-1007.
30. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-AizawaY, Saido TC (2000) Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat Med 6, 143-150.
31. Tampellini D, Rahman N, Gallo EF, Huang Z, Dumont M, Capetillo-Zarate E, Ma T, Zheng R, Lu B, Nanus DM, Lin MT, Gouras GK (2009) Synaptic activity reduces intraneuronal Abeta, promotes APPtransport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 29, 9704-9713.
32. Tampellini D, Rahman N, LinMT, Capetillo-Zarate E, Gouras GK (2011) Impaired beta-amyloid secretion in Alzheimer's disease pathogenesis. J Neurosci 31, 15384-15390.
33. Fisk L, Nalivaeva NN, Boyle JP, Peers CS, Turner AJ (2007) Effects of hypoxia and oxidative stress on expression of neprilysin in human neuroblastoma cells and rat cortical neurones and astrocytes. Neurochem Res 32, 1741-1748.
34. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H (2005) Oxidative stress in obstructive sleep apnea. Chest 127, 1674-1679.
35. Sun X, He G, Qing H, ZhouW, Dobie F, Cai F, Staufenbiel M, Huang LE, Song W (2006) Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A 103, 18727-18732.
36. Li L, Zhang X,Yang D, Luo G, Chen S, LeW(2009) Hypoxia increases Abeta generation by altering beta- and gammacleavage of APP. Neurobiol Aging 30, 1091-1098.
37. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, Xu H, Zhang YW (2007) Hypoxia-inducible factor 1alpha (HIF- 1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J Biol Chem 282, 10873-10880.
38. Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112, 2660- 2667.
39. Tomita S, Fujita T, Kirino Y, Suzuki T (2000) PDZ domaindependent suppression of NF-kappaB/p65-induced Abeta42 production by a neuron-specific X11-like protein. J Biol Chem 275, 13056-13060.
40. Nanduri J, Nanduri RP (2007) Cellular mechanisms associated with intermittent hypoxia. Essays Biochem 43, 91-104.
41. Barcelo A, Miralles C, Barbe F, Vila M, Pons S, Agusti AG (2000) Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 16, 644-647.
42. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124, 1386-1392.
43. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI (2003) Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 7, 105-110.
44. Lavie L (2003) Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 7, 35-51.
45. Suzuki YJ, Jain V, Park AM, Day RM (2006) Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40, 1683-1692.
46. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (2006) Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 65, 631- 641.
47. Ng KM, Lau CF, Fung ML (2010) Melatonin reduces hippocampal beta-amyloid generation in rats exposed to chronic intermittent hypoxia. Brain Res 1354, 163-171.